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Abstract
In the context of radiotherapy, collateral effects of ablative doses of ionizing radiation (AIR) on stromal components
of tumors remains understudied. In this work, cancer-associated fibroblasts (CAFs) isolated from freshly resected
human lung tumors were exposed to AIR (1× 18 Gy) and analyzed for their release of paracrine factors. Inflamma-
tory mediators and regulators of angiogenesis and tumor growth were analyzed by multiplex protein assays in
conditioned medium (CM) from irradiated and non-irradiated CAFs. Additionally, the profile of secreted proteins
was examined by proteomics. In functional assays, effects of CAF-CM on proliferative and migratory capacity of
lung tumor cells (H-520/H-522) and human umbilical vein endothelial cells (HUVECs) and their tube-forming
capacity were assessed. Our data show that exposure of CAFs to AIR results in 1) downregulated release of
angiogenic molecules such as stromal cell-derived factor-1, angiopoietin, and thrombospondin-2 (TSP-2); 2) up-
regulated release of basic fibroblast growth factor from most donors; and 3) unaffected expression levels of
hepatocyte growth factor, interleukin-6 (IL-6), IL-8, IL-1β, and tumor necrosis factor–α. CM from irradiated and con-
trol CAFs did not affect differently the proliferative or migratory capacity of tumor cells (H-520/H-522), whereas
migratory capacity of HUVECs was partially reduced in the presence of irradiated CAF-CM. Overall, we conclude
that AIR mediates a transformation on the secretory profile of CAFs that could influence the behavior of other cells
in the tumor tissue and hence guide therapeutic outcomes. Downstream consequences of the changes observed in
this study merits further investigations.
Translational Oncology (2013) 6, 66–74
Introduction
Non–small cell lung carcinoma (NSCLC) accounts for 80% of all
lung cancers, and the combination of high incidence with high mor-
tality rates make NSCLC one of the deadliest cancer types globally
[1]. Radiation therapy (RT) continues to be a cornerstone in the
treatment of NSCLC, but RT of the thorax is typically limited by
the sensitivity of normal lung tissue and the risk of damage to the
myocardium. To minimize adverse reactions in healthy tissues, con-
ventional radiotherapy typically consists of daily doses of 2 Gy
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administered over several weeks [2]. However, advances in RT tech-
nology now permit accurate delivery of ablative (high) radiation
doses to small early-stage tumors in few fractions (<5), with minimal
exposure to surrounding normal tissue and therefore acceptable tox-
icity [3,4]. This novel method of delivering therapeutic ionizing
radiation is termed stereotactic ablative radiation therapy (SART).
Emerging outcomes from prospective, multi-institutional clinical
trials indicate that SART has particular impact on inoperable
NSCLC tumors, resulting in considerable improvement of local
control and overall survival compared with conventional RT regi-
mens [5,6]. SART in the context of peripheral early-stage inoperable
NSCLC is typically delivered in three fractions of 18 Gy [4] and rep-
resent a long-sought breakthrough for curative lung cancer therapy [7].
The notion that tumor progression is not restricted to proliferating
neoplastic cancer cells, but also relies on the concomitant develop-
ment of a supportive tumor microenvironment, is now solidified
within the scientific community [8–11]. In line with these insights,
recent therapy-oriented studies have challenged the view that (high-
dose) RT efficacy depends exclusively on direct tumor cell killing,
arguing that also indirect regulatory mechanisms emerging from
the surrounding stromal components must be taken into consider-
ation [12,13]. One plausible contributing factor to high-dose RT effi-
cacy is the induction of effective immune responses [14,15]. Ablative
RT, in contrast to standard RT regimens, reportedly recruits greater
numbers of host immune cells into the irradiated tumor volume
[16], activates dendritic cells [17], and generates a T cell–dependent
immune response that contributes to local tumor reduction and even
eradication of distant metastasis in some circumstances [18]. Effects on
the tumor vasculature also seems to become evoked by high-dose RT
[19], as irradiation of tumor endothelial cells in vitro revealed a thresh-
old dose of 1× 10 Gy for induction of apoptosis, with 43% of cells
becoming apoptotic after 1× 17 Gy [20].
Cancer-associated fibroblasts (CAFs)—often representing the
most abundant cell type of the tumor stroma—is an additional ele-
ment involved in the regulation of epithelial carcinogenesis [21–24].
Such reactive tumor-resident fibroblasts contribute to cancer devel-
opment predominantly by the release of paracrine signals that regu-
late the behavior of other cells in the tumor mass but also stimulate
recruitment of endothelial precursor cells [25] and monocytes [26].
Furthermore, CAFs have been nominated as the “leader cell” in the
process of collective cancer cell invasion [27], and primary lung tumor
CAFs has been found in brain metastases derived from lung carci-
noma [28]. Yet, despite the prominent role that fibroblasts play on
cancer sustainability, the impact exerted by single high radiation doses
(>2 Gy) on tumor-resident fibroblasts is largely unexplored.
In the context of radiotherapy, some groups have shown convinc-
ingly that radiation-induced effects in the stromal microenvironment
can contribute to malignant progression in vivo [29]. In xenograft
models, senescent fibroblasts co-transplanted with cancer cells have
been found to increase stimulatory effects on cancer growth [30].
Indeed, the transformed phenotype acquired by radiated stromal cells
could influence tumor development by the release of senescent cell
products, such as matrix metalloproteinases, inflammatory cytokines,
or diverse growth factors [31]. Altogether, a growing body of evi-
dences is thus supporting the notion that CAFs may survive radiation
exposure, and they are therefore likely to become central players in
the regulation of cancer recurrence and resistance to targeted thera-
pies [32–34]. However, it is still unresolved if this phenomenon is
tumor type specific or organ specific or whether the senescent pheno-
type acquired after high-dose radiation exposure is comparable to
other forms of senescence [35].
In a recent study from our laboratory, we show that CAFs survive
after ablative doses of ionizing radiation (AIR; 1× 18 Gy); however,
the cellular phenotype becomes profoundly altered, characterized by
the development of senescence and the concomitant induction of
growth arrest [36]. We have seen that a single dose of 18 Gy happens
to be sublethal for CAFs and that radiation doses above 12 Gy
induce enduring DNA damage responses (nuclear foci of 53BP1)
and push cells into the permanent senescence stage. Of note, in that
study we show that the expression of some matrix metalloproteinases
becomes altered along with an overexpression of cell surface integ-
rins, which all together results in a reduction of the migratory and
invasive capacity of CAFs. In this preceding study from our group,
we describe in detail the isolation and characterization of the
NSCLC-derived fibroblast cultures that have been used also for this
study. Importantly, flow cytometry analyses using the fibroblast-
specific markers α-smooth muscle α-actin and fibroblast activation
protein revealed a purity above 99.7%, which gives full credibility
to the data generated with this material. This work is intended to
complement our initial study on radiation-induced responses by
CAFs. Following the rationale of using single high radiation doses
to reproduce the effects provoked by SART regimens, in this study
we investigate AIR-induced responses mediated by CAFs, with empha-
sis on paracrine signals that are known to be directly involved in regu-
lation of cancer cell growth and development of tumor vasculature.
Materials and Methods
Human Material, Cell Isolation, and CAF Cultures
Human CAFs were isolated from freshly resected NSCLC tissue
specimens, as described previously [36]. Tumors from seven patients
not otherwise treated and with an average age of 61 years (range, 51–
78) were included in this study. The Regional Ethical Committee
approved the study, and all patients provided written informed con-
sent. Fibroblasts from tumors were isolated and characterized follow-
ing standard procedures. Briefly, tumor resections were collected and
cut into 1- to 1.5-mm3 pieces. Enzymatic digestion of tissues was
carried out for 1.5 hours in 10 ml of Dulbecco’s modified Eagle’s
medium/HAM’S F-12 containing bacterial collagenase (Cat. No.
C-9407 Sigma-Aldrich, St Louis, MO) at a final concentration of
0.8 mg/ml. Digested tissue was spun for washing and resuspended
in fresh growth medium (Dulbecco’s modified Eagle’s medium/
HAM’S F-12 supplemented with 10% FBS). Pure fibroblast cultures
were obtained by selective cell detachment from the primary culture
mix and by further cell propagation in the presence of 10% FBS.
Cells were grown at 3% oxygen and were characterized for purity
and cell identity by 1) flow cytometry using fluorescein isothiocyanate–
conjugated anti-human α–smooth muscle α-actin antibody (Abcam,
Cambridge, United Kingdom; Cat. No. ab8211) [10] and 2) immuno-
fluorescent staining with anti–fibroblast activation protein antibody,
a marker for reactive fibroblasts [37].
Cell Lines
Human NSCLC cell lines were cultivated in Nunc EasYFlasks
Nunclon Δ (Cat. Nos. 156367 and 156499) in RPMI 1640 medium
supplemented with 10% heat deactivated FBS, 4 mM L-glutamine,
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and antibiotics. Before the experiments, the cultures were kept in
humidified incubators at 37°C with 5% CO2. Human NSCLC cell
lines H522 (Cat. No. NCI-H522 adenocarcinoma) and H520 (Cat.
No. NCI-H520 squamous cell carcinoma) were obtained from the
American Type Culture Collection (ATCC,Manassas, VA) and cultured
as described above. Primary human umbilical cord endothelial cells
(HUVECs) were also purchased from ATCC (Cat. No. PCS-100-010).
Cell authentication tests and certificates were provided by themanufacturer.
Irradiation of Cells
The intrinsic radioresistance of CAFs in dose-escalating trial experi-
ments have been evaluated and described by us previously [36]. Briefly,
adherent CAFs cultured in flasks were irradiated with high-energy
photons produced by a Varian clinical linear accelerator, delivered as
single doses of 2, 6, 12, and 18 Gy or after fractionated 6× 3 Gy.
Standard parameters for dose delivery were depth of 30 mm, beam
quality of 15 MV, dose rate of 6 Gy/min, and field size of 20 × 20 cm.
Radiation doses were confirmed by thermoluminescent dosimeters.
Cell death after radiation was assessed by xCELLigence and by light
microscopy for 3 weeks after radiation exposure. Standard assays to test
viability such as 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) and clonogenic survival could not be used in our
CAF culture system because the differences observed after long incu-
bation periods between irradiated and non-irradiated cells were a con-
sequence of premature cell senescence rather than cell death.
Preparation of Conditioned Medium
CAF cultures were established from five randomly selected and
untreated donors and grown in T75 culture flasks at low oxygen
(3%), followed by irradiation (1× 18 Gy) of semiconfluent cells.
Culture medium from irradiated and control CAFs was collected
between days 4 and 6 post-irradiation. Supernatants were spun down
and filtered for elimination of potential contaminant cell bodies.
Finally, the collected medium was concentrated in VIVASPIN
(3000-MW cutoff size).
Fluorescent Bead-Based Fluorokine Multianalyte Profiling
Assay (Luminex; Bio-Rad, Hercules, CA)
Quantitative measurements of cytokines and growth factors were
performed using a suspension array technique (Bio-Plex 200; Bio-Rad)
[38,39]. CAF–conditioned medium (CM) from five randomly se-
lected donors was prepared as indicated previously. Protein levels of in-
flammatory factors [tumor necrosis factor–α (TNF-α), interleukin-1β
(IL-1β), IL-6, and IL-8] and growth factors [hepatocyte growth factor
(HGF), basic fibroblast growth factor (bFGF), platelet-derived growth
factor (PDGF), and vascular endothelial growth factor (VEGF)] were
analyzed in a cytokine multiplex panel (Cat. No. 171B5026M, Bio-
Rad), and angiogenic factors were examined with a multiplex panel
(Cat. No. LAN1635, LAN265, LAN 923; R&D Systems, Abingdon,
United Kingdom). All samples were analyzed in duplicates and in dilu-
tions of 1:4. Levels of proteins included in the arrays were detected
using the Bio-Plex 200 analyzer, according to instructions from the
manufacturer. Data were processed using SPSS statistical software ver-
sion 16.0 (SPSS Inc, Chicago, IL). The secretion levels were examined
for statistical significance using the Wilcoxon signed-rank test. Only
readings above the detection limit of the assay are represented in figures.
The values are expressed as mean ± SEM. A P value < .05 denoted the
presence of a statistically significant difference.
Analyses of the Secretome by Proteomics and Exponentially
Modified Protein Abundance Index Calculation
CAF supernatants from irradiated and non-irradiated cells were
collected between days 4 to 6 post-treatment, concentrated in
VIVASPIN (3000-MW cutoff) centrifuge tubes, and run in one-
dimensional sodium dodecyl sulfate–polyacrylamide gel electro-
phoresis. Upon staining of gels with Coomassie blue, the entire band
spectrum in the gels from each supernatant was excised into 24 gel
fractions. After excision, gel bands were subjected to in-gel reduction,
alkylation, and digestion using 2 to 10 ng/μl trypsin (V511A; Promega,
Madison, CA) [40]. Peptide mixtures containing 0.1% formic acid were
loaded onto a nanoACQUITY UltraPerformance LC (Waters, Milford,
MA), containing a 3-μmSymmetry C18Trap column (180 μm× 22mm;
Waters) in front of a 1.7-μm BEH130 C18 analytical column (100 μm ×
100 mm; Waters). Peptides were separated with a gradient of 5% to
95% acetonitrile and 0.1% formic acid, with a flow of 0.4 μl/min eluted
to a Q-TOF Ultima mass spectrometer (Micromass/Waters). Samples
were run in data-dependent tandemmass spectrometry (MS) mode. The
relative abundance of proteins was calculated using the Exponentially
Modified Protein Abundance Index (emPAI) [41]. Briefly, peak lists
were generated fromMS/MS byMascot Distiller 2.3.2 (Matrix Sciences,
Boston, MA). All raw data files from one patient were merged into one
mascot generic file (MGF) peak list. The resulting MGF files were
searched against the Swiss-Prot 57.15 protein sequence databases using
an in-house Mascot 2.3 server (Matrix Sciences). Peptide mass tolerances
used in the searchwere 100 ppm, and fragmentmass tolerancewas 0.1Da.
The emPAI was collected from themascot results for each protein ID.
Real-Time Monitoring of Cell Growth in
xCELLigence E-plates
Proliferation rates were monitored continuously by exploiting the
xCELLigence System from Roche Applied Sciences (Indianapolis, IN),
consisting of microtiter E-plates with gold microarrays integrated in
bottom of wells and the RTCA-DP instrument for plate readouts, pre-
viously described by us [36] and others [42–44] . Briefly, tumor cells
(H520 and H522) and endothelial cells (HUVECs) were seeded in
E-plates at densities of 10,000 and 5000 cells/well, respectively. Upon
attachment (initial 3 hours), cells received (1:1) volumes of CAF-CM)
from irradiated and non-irradiated cells prepared from three different
donors. Automated real-time monitoring of E-plates was performed
by the RTCA-DP instrument at standard incubator conditions, with
triplicate readouts of the dimensionless parameter cell index every
30 minutes during the following 7 days.
Real-Time Monitoring of Cellular Migration in
xCELLigence CIM Plates
Onset and rate of migration was monitored continuously by
exploiting the Cell-Invasion-and-Migration (CIM) plates corre-
sponding to the xCELLigence System, described previously [36,45].
In this study, migration assays were performed as follows: Tumor cells
(H520 and H522) and endothelial cells (HUVECs) were seeded in
the upper chamber of CIM plates at densities of 50,000 cells/well for
tumor cell lines (H520 andH522) and 30,000 cells/well for endothelial
cells. The lower and upper chambers of the CIM plates were filled with
1:1 dilution of CAF-CM mixed with each cell line–specific growing
medium. Upon equilibration (1-hour incubation at room tempera-
ture), CIM plates were transferred into the RTCA DP instrument
for readouts every 15 minutes during 48 hours. Impedance (cell index)
was registered only from cells capable of migrating through the 8-μm
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porous membrane, and readout was performed in three parallel wells
per condition.
In Vitro Tubule Forming Assay
The formation of capillary-like structures was assessed in Matrigel-
coated multiwell plates essentially as described [46]. HUVECs at
early passages were collected and seeded at a density of 5 × 104 cells/
well in 24-well plates coated with 230 μl of Matrigel (BD, Cat.
No. 356231). Cell attachment was allowed during the initial 2 hours
at 37°C and from then on HUVECs were exposed to CAF-CM mixed
in a 1:1 proportion with serum-free HUVECmedium. Incubation was
carried out for 20 hours thereafter. Formation of tubular structures
was examined with a Nikon Eclipse TS100 model light microscope.
Randomly selected fields were photographed at ×40 magnification,
using an Idea SPOT digital camera. Capillary-like tubular structures
were scored by counting the number of tubules in each well (numbers
were extrapolated from counting three randomly selected microscope
fields per well). Data are the means ± SD from three independent
experiments, each performed in duplicates.
Results
Secretion of Paracrine Factors Regulating Tumor Growth,
Inflammation, and Angiogenesis
CAFs are thought to exert most of their tumor promoting func-
tions through expression of paracrine molecules that either directly
stimulates growth of cancer cells or influence growth and functions
of other cells from the tumor stroma. Thus, we studied the impact of
AIR (1× 18 Gy) on expression of a panel of factors known to be
important regulators of inflammation, angiogenesis, or tumor growth,
using antibody-based multiplex protein arrays in supernatants derived
from reactive CAF cultures from various donors. Our results show
that while a number of major inflammatory/immune mediators such
as IL-6 and IL-8 and also TNF-α are readily produced by CAFs, secre-
tion of these factors is not modified by AIR (Figure 1A ). Another
important immunoregulator, IL-1β, was not detected in CAF–culture
supernatants (not shown). In the case of angiogenic regulators, CAFs
expressed all five factors included in the array (Figure 1B ). Of these,
AIR caused a significant reduction (P < .05) in expression of stromal
cell-derived factor-1α (SDF-1α), angiopoietin-1 (ANG-1), and TSP-2.
Among the various growth factors studied, HGF and, to a lesser extent,
bFGF were produced by CAFs, whereas PDGF was not detected
(Figure 1C ). Interestingly, a potent induction of bFGF (∼10 fold
in some donors) was observed in irradiated CAFs from four out of
five donors, whereas secretion of the other studied growth factors was
not changed.
Proteomic Analyses of the CAF Secretome after AIR
To undertake an unbiased assessment and to search for novel or
alternative paracrine signals released by CAFs that may influence
tumor development, the entire secretome was analyzed by proteo-
mics and the relative abundance of detected proteins estimated using
the emPAI. On average, a total of 135 proteins with acceptable
mascot scores were identified in supernatants of non-irradiated cells
and 181 proteins in supernatants of irradiated cells. Identified pro-
teins were classified by functionality (data not shown). The most
abundantly expressed protein types were matrix components and
Figure 1. Secretion of tumor regulatory molecules by irradiated
and non-irradiated CAFs. Quantitative determinations of growth
factors and cytokines in culture supernatants from five different
donors were measured by multiplex protein arrays. Only factors
giving values above the detection limit of the assay are rep-
resented. Panel (A) demonstrates expression of inflammatory
molecules. The following cytokines were included in the array:
IL-1β, IL-6, IL-8, and TNF-α. Panel (B) shows array of angiogenic
factors including SDF-1α, angiogenin, angiopoietin, TSP-2, and
VEGF. Finally, (C) presents array of detectable tumor growth reg-
ulators, comprising HGF, bFGF, and PDGF. Mean values from five
different donor samples are shown; statistical analyses were per-
formed by applying paired samples Student’s t test. Statistically
significant differences are indicated by asterisk (P < .05).
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matrix regulatory molecules. Other protein types included metabolic
enzymes, binding proteins, and inhibitory or stimulatory growth
factors. Regarding inflammatory mediators, angiogenic factors, and
tumor growth regulators, only eight relevant factors could be iden-
tified in all or some of the donors (Table 1). In line with the data
generated bymultiplex protein arrays, we observed a reduction (approx-
imately 1.4-fold) in the expression of angiogenic regulators such as
TSP-1 and TSP-2 after applying semiquantitative determinations to
compare irradiated and non-irradiated CAFs. Expression of the inflam-
matory mediator IL-6 was found to be reduced in the supernatants in
which it was detected (2.8-fold), whereas expression of macrophage
migratory inhibitory factor was enhanced (3.4-fold). Other tumor
growth regulators modified by AIR were insulin-like growth factor 2
(IGF-2; not detected on 0 Gy), connective tissue growth factor (CTGF;
3.5-fold downregulated), and growth arrest-specific protein 6 (GAS-6;
1.9-fold upregulated).
Effects of Secreted Molecules on the Proliferative and
Migratory Capacity of Lung Neoplastic Cells
To determine if secreted factors from irradiated and/or non-
irradiated CAFs influenced the proliferative and invasive capacity
of epithelial tumor cells, H520 lung squamous carcinoma cells and
H522 lung adenocarcinoma cells were exposed to CAF-CM isolated
from different random donors. Proliferation of tumor cells was moni-
tored continuously over a 1-week period on E-plates. Results showed
no influence of CAF-CM on the proliferation rate of either H520
(Figure 2A ) or H522 tumor cells (Figure 2B ). Similar outcomes were
observed after using fibroblast CM prepared from three different
Table 1. List of Tumor Regulatory Agents Identified in CAF Supernatants by Proteomics.
Protein Name Positive ID* Protein Acronym† Mascot Score Protein Cover emPAI 0 Gy emPAI 18 Gy Fold Change 0 versus 18 Gy
Pigment epithelium–derived factor n = 4 PEDF 319 34.7 0.59 (±0.3) 0.15 (±0.1) ↓ 3.9
Thrombospondin-1 n = 5 TSP-1 434 17.6 0.46 (±0.3) 0.33 (±0.1) ↓ 1.4
Thrombospondin-2 n = 2 TSP-2 233 7.7 0.10 (±0.06) 0.07 (±0.1) ↓ 1.4
Insulin-like growth factor 2 n = 1 IGF-2 59 6.1 – 0.19 –
Growth arrest-specific protein 6 n = 4 GAS-6 363 18.3 0.13 (±0.1) 0.25 (±0.2) ↑ 1.9
Macrophage migratory inhibitory factor n = 2 MIF 77 17.4 0.15 (±0.2) 0.51 (±0.2) ↑ 3.4
Connective tissue growth factor n = 2 CTGF 47 4.8 0.14 (±0.07) 0.04 (±0.0) ↓ 3.5
Interleukin-6 n = 2 IL-6 158 22.2 0.48 (±0.4) 0.17 (±0.2) ↓ 2.8
emPAI: Average values from positive determinations.
*Number of donors in which the protein was identified from a total of five analyzed.
†Human.
Figure 2. Effect of CAF-CM on proliferative and migratory capacity of lung tumor cell lines H520 and H522. CAFs cultured in T-75 flasks
were treated with 1× 18 Gy and medium was conditioned in a serum-free setting for 4 to 6 days post-irradiation. Proliferative capacity of
two lung carcinoma cell lines, H520 (squamous cell carcinoma) (A) and H522 (adenocarcinoma) (B), was monitored on E-plates located
in the xCELLigence machine, whereas corresponding migratory capacity of H520 and H522 in double-chambered CIM plates is pre-
sented in (C) and (D), respectively. For both experiments, H520 and H522 were exposed to (1:1) non-irradiated CAF-CM (red line) and
(1:1) irradiated CAF-CM (green line) from a randomly selected donor. Similar profiles were obtained after running the assay with CAF-CM
from three different donors.
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donors (data not shown). In a different set of experiments, the
migratory capacity of H520 (Figure 2C ) and H522 tumor cells
(Figure 2D) was compared in the presence of CAF-CM from irra-
diated (18 Gy) or non-irradiated (0 Gy) CAFs over a 48-hour period.
Using this system, migration of H520 cells was nearly undetectable,
and changes in migration rates could not be measured. However,
H522 cells migrated efficiently, but CAF-CM did not significantly
affect this behavior.
Effects of Secreted Molecules on the Proliferative and
Migratory Capacity of Endothelial Cells (HUVECs)
To determine if secreted factors from irradiated and non-irradiated
CAFs had influence on the proliferative and migratory capacity of
endothelial cells, HUVECs were exposed to CAF-CM isolated from
three different donors. Proliferation of HUVECs was monitored con-
tinuously over 1 week on E-plates by the xCELLigence System. The
results showed that 1) HUVECs lose their proliferative capacity in
the absence of serum (seen as flattening of cell index values) and
2) CM from irradiated and non-irradiated CAFs had no influence
on the proliferation rates of HUVECs (Figure 3A ). Similar outcomes
were observed with CAF-CM from three different donors (data not
shown). Regarding migration, unlike for tumor cell lines, CAF-CM
was essential to promote migration of HUVECs in the absence of
serum. Interestingly, CAF-CM from irradiated cells resulted in a
considerable reduction of the migratory capacity of HUVECs when
compared to CAF-CM from non-irradiated cells (Figure 3B ). Migra-
tory activity of HUVECs exposed to CM from irradiated CAFs
(CAF-CM 18 Gy) was on average 26% lower than for HUVECs
exposed to CM from non-irradiated CAFs, when calculating cell
index values after 20 hours of observation in CIM plates (Figure 3C ).
For the quantitative data (Figure 3C), CI values reflect average numbers
from seven independent experiments and readouts by the xCELLigence
System, using CAF-CM from seven randomly selected donors. Never-
theless, statistical analyses with this number of donors using Wilcoxon
signed-rank test revealed P = .06.
Effects of Secreted Molecules on Endothelial Cell
Tube Formation
To further investigate the effects of CAF-released paracrine signals
on endothelial cell behavior, we performed endothelial cell tube forma-
tion assays in the presence of CAF-CM. This widely used in vitro
angiogenesis assay intends to visualize and quantify formation of
capillary structures in a basement membrane matrix, hence allowing
scientists to explore compounds that promotes or inhibits angio-
genesis. Using this assay, we found that HUVECs grown in the pres-
ence of standard HUVEC incubation media do indeed make tubes
(Figure 4A) but with a much lower quantity and quality than HUVECs
exposed to CAF-CM (Figure 4B ), i.e., 417 versus 721 tubes/well,
respectively. Tube-forming capacity of HUVECs exposed to CM from
non-irradiated versus irradiated CAFs demonstrated similar morphol-
ogy and also similar numbers in respect to tube formation, 721 versus
672 tubes/well, respectively (Figure 4C ).
Discussion
In this study, we have mapped the CAF-mediated release of signaling
molecules implicated in inflammation, angiogenesis, and tumor
growth and have examined the impact of such radiation-induced dis-
turbances on growth and proliferation of tumor cells and endothelial
cells. Our results show that important tumor-regulatory molecules
released by CAFs are differentially regulated after exposure to AIR.
Of note, a number of angiogenic factors including SDF-1, angio-
poietin, and TSP-1 are downregulated, whereas molecules such as
bFGF are upregulated. In functional assays with lung tumor cell lines
and endothelial cells we have not observed considerable changes in
the growth or migratory properties of cells, besides the moderate
downregulated migration of HUVECs exposed to irradiated CAF-CM.
Although in our experimental system the pull of released factors from
CAF was not able to induce significant regulation of the mentioned
cell functions, an altered secretion of signal molecules upon AIR
does occur and warrant close attention.
In a recently publishedwork, we reported that after exposure to a single
radiation dose of 18 Gy, CAFs develop a senescent phenotype with
reduced migratory and invasive capacities, and these phenomena were
Figure 3. Effect of CAF-CM on the proliferative and migratory
capacity of HUVECs. CAFs were treated with 1× 18 Gy and incu-
bation medium was conditioned in serum-free conditions for 4 to
6 days post-irradiation. Proliferative capacity of HUVECs was
monitored on E-plates (A) and migratory capacity in double-
chambered CIM plates (B), with readout by the xCELLigence
System for both types of plates. For both experiments, HUVECs
were exposed to (1:1) non-irradiated CAF-CM (red line), and (1:1)
1× 18 Gy irradiated CAF-CM (green line) from one randomly se-
lected donor. Similar profiles were obtained after running the
assay with CAF-CM from seven different donors. Columns in
(C) represent mean and SEs of CI values after a 20-hour observa-
tion of HUVEC migratory behavior, averaged from seven indepen-
dent experiments using CAF-CM from seven randomly selected
donors. Error bars represent SD.
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attributable to stabilization and redistribution of focal contacts within
the plasma membrane [36]. In that study, we also showed that expres-
sion of matrix-degrading enzymes such as matrix metalloproteinase-1
is downregulated (in four out of five donors) after AIR. Other lab-
oratories have also shown that ionizing radiation can provoke a
senescence-like phenotype in fibroblasts receiving a single dose of
10 Gy [31]. Previous reports argue that after both replicative senescence
[47] and stress-induced senescence, fibroblasts (cell lines) and malig-
nant cells acquire an activated phenotype characterized by increased
production of proteolytic enzymes, cytokines, growth factors, and
reactive oxygen species that promote tumor growth and survival
[30,31,47–49]. However, the overall tumor regulatory properties of
senescent fibroblasts remain controversial. Some authors have suggested
that cancer promotion by senescent stromal cells may be restricted to
certain organ and tissue types and claim that the importance of senes-
cent cells needs to be validated in other sites than subcutaneously grown
tumors [35].
Activated fibroblasts undeniably represent an important source of
cytokines and immunomodulators that influence the inflammatory
process during tumor development [10,23,50]. Our data confirm
that reactive lung CAFs indeed produce cytokines such as IL-6,
IL-8, and TNF-α, whereas molecules such as IL-1β were below the
limits of detection. Hanahan et al. have demonstrated, similarly to us,
that CAFs from skin, breast, or pancreatic cancers possess a pro-
inflammatory gene signature that is already activated in CAFs before
irradiation, including upregulated levels of IL-6 in CAFs versus normal
fibroblasts as well as low levels of IL-1β [51]. In accordance with another
study [52], we observed that AIR do not alter significantly the produc-
tion of any of these cytokines in CAFs. On the opposite, others have
shown that large single radiation doses (10 Gy) induce senescence in
(diploid) fibroblasts and that this phenotype is featured by a marked
induction of IL-6 and IL-8 production that could promote tumor pro-
gression [31]. These discrepancies may be attributed to the differences
in the experimental models used. We are one of few groups using
freshly isolated CAFs from tumor specimens derived from multiple
donors. Other laboratories are using long-passage cell lines derived
initially from normal tissue fibroblasts, displaying phenotypes that may
have been altered by prolonged culturing. For a proper interpretation of
results, the activated nature of tumor-resident fibroblasts has to be taken
into consideration.
In this study, we have also explored the secretion of CAF-derived
growth factors that may exert a direct impact on tumor growth [53]
as well as resistance to molecularly targeted therapies [54]. Our data
show that some recognized growth factor molecules, such as HGF
and to a lesser extent bFGF, are secreted by NSCLC-derived CAFs.
After exposure to AIR, secreted bFGF levels from CAFs were notice-
ably enhanced, whereas HGF levels were unchanged. These findings
are in agreement with results achieved by exposing stromal fibroblasts
from pancreatic cancer to 1× 10 Gy [53]. Notably, fibroblast growth
factor-2 (or bFGF) is reported to mediate radioprotective effects on
the tumor vasculature [55] and also function as an independent neg-
ative predictor of local tumor control and overall survival for patients
irradiated for stage II to III NSCLC [56]. However, recent studies
have demonstrated HGF-induced resistance to anti-tumoral effects
mediated by epidermal growth factor receptor–tyrosine kinase inhib-
itors in lung cancer [32], triple-negative breast cancer [33], and also
BRAF-mutant melanomas [34,57]. Accordingly; inhibition of HGF
activity has demonstrated enhanced therapeutic responses in lung [58]
and pancreatic cancers [53]. PDGF, a relevant tumor regulatory mol-
ecule that can be expressed by tumor fibroblasts, was not detected in
NSCLC-CAF supernatants by us. These contradictory observations
could be explained by tissue-specific patterns of secretion from CAFs
of different tumor types.
In our unbiased proteomic approach, we could detect expression
of other important tumor growth regulators such as IGF-2, CTGF,
Figure 4. Effect of CAF-CM on endothelial cell tube formation.
CAFs were treated with 1× 18 Gy and incubation medium was
conditioned in serum-free conditions between days 4 and 6
post-irradiation. HUVECs were plated in Matrigel-coated multiwell
plates, and after an attachment phase of 2 hours, HUVECs were
exposed to CM from irradiated (18 Gy) and non-irradiated CAFs
(0 Gy) and incubated for another 20 hours. Images show tube
formation by HUVECs after 20 hours of growth in Matrigel. In
(A), tube formation by HUVECs exposed to standard (cell-free)
incubation medium is shown, whereas (B) and (C) demonstrate
tube-forming HUVECs exposed to CM from non-irradiated CAFs
(CAF-CM 0 Gy) and irradiated CAFs (CAF-CM 18 Gy), respectively.
Bars, 320 μm. Panel (D) reflects quantification of HUVEC forming
tubes/well. Data represent average values from three independent
experiments (error bars represent SD).
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GAS-6, and pigment epithelium–derived factor (PEDF). Semi-
quantitative determinations show that while the expression of the
pro-tumorigenic macrophage migration inhibitory factor [59] and the
senescent marker GAS-6 were enhanced upon radiation, expression of
the matrix regulatory molecule CTGF and the anti-tumorigenic factor
PEDF were reduced. Notably, it has been recently suggested that
metabolically reprogrammed and CTGF-overexpressing CAFs are
mediating growth of breast cancer cells, without a concomitant increase
in angiogenesis [60]. Results from our functional studies, using H522
adenocarcinoma and H520 squamous cell carcinoma cell lines derived
from NSCLC, did not reveal any perturbation of the proliferative or
migratory capacity of tumor cells exposed to CAF-CM. This may
indicate that the observed changes in the secretory profile of CAFs upon
AIR do not exert a measurable impact on the adjacent lung tumor cells.
However, it should be kept in mind that our functional assays were
performed on cell lines in cell culture conditions that may or may
not represent the behavior of lung carcinoma cells in vivo.
Moreover, we have explored the CAF-mediated effects of AIR on
the expression of major regulators of angiogenesis. The role of CAFs
as providers of pro-angiogenic factors is well documented [10,25].
Indeed, in many instances, angiogenic inducers expressed within
tumors are produced in higher quantities by stromal cells than by the
tumor cells themselves [61]. Importantly, the secretion of SDF-1 by
CAFs enhances the recruitment of endothelial progenitor cells into
the tumor neovasculature, thereby promoting neovasculogenesis
[25,62] and eventually tumor recurrence. To our knowledge, regula-
tion of the angiogenic response by irradiated CAFs has not been docu-
mented hitherto. Our data show that VEGF is abundantly expressed
by CAFs, but its expression is not consistently modified by AIR. How-
ever, production of factors such as angiopoietin and SDF-1 was sig-
nificantly reduced in irradiated CAFs, along with a reduction of the
anti-angiogenic factor TSP-2. In line with the results obtained by
multiplex protein assays, TSP-1 and TSP-2 were found to be down-
regulated by AIR in our proteomic analyzes. To investigate the relevance
of these findings, we performed functional assays that demonstrated
that, while the proliferative capacity of endothelial cells was unaltered
after exposure to CM from irradiated CAFs, their migratory capacity
was reduced. In tube-forming assays, endothelial cells were showing
dependence on CAF-CM to form stable capillary-like structures in
serum-free conditions; however, irradiation of CAFs did not introduce
measurable differences in this functional assay. Our study did not
include in vivo measurements of the recruitment of endothelial pro-
genitors, but taken together our data support the notion that exposure
of CAFs to high radiation doses causes a significant reduction in some of
their pro-angiogenic properties. This conclusion does not rule out the
possibility that radiation might induce pro-angiogenic effects through
tumor components other than CAFs.
Conclusions
Central paracrine molecules released by CAFs that are implicated in
overall tumor sustainability are differentially regulated upon AIR.
Thus, whereas the expression of a number of major inflammatory
mediators remains unchanged, growth factors such as bFGF are up-
regulated. In addition, the CAF-mediated angiogenic response appears
to be inhibited by AIR: The migratory capacity of endothelial cells is
reduced in the presence of CM from irradiated CAFs, and the expres-
sion of angiogenic inducers such as angiopoietin and SDF-1 is signifi-
cantly reduced. Overall, our results suggest that some of the beneficial
therapeutic effects of AIR could be linked to a reduction of the tumor
promoting properties of CAFs, but the overall impact of such distur-
bances in vivo remains to be studied.
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